Free 7-day Trial
All Articles and Columns »

BioMarin Pharmaceutical Inc. (BMRN) CEO Jean Jacques Bienaime sells 7,000 Shares

November 13, 2012 | About:
insider

insider

52 followers
CEO of BioMarin Pharmaceutical Inc. (BMRN) Jean Jacques Bienaime sells 7,000 shares of BMRN on 11/09/2012 at an average price of $47.62 a share.

Biomarin Pharmaceutical, Inc. has a market cap of $5.94 billion; its shares were traded at around $48.44 with and P/S ratio of 13.5.

This is the annual revenues and earnings per share of BMRN over the last 10 years. For detailed 10-year financial data and charts, go to 10-Year Financials of BMRN.


CEO Recent Trades:



  • CEO Jean Jacques Bienaime sold 7,000 shares of BMRN stock on 11/09/2012 at the average price of 47.62. Jean Jacques Bienaime owns at least 167,691 shares after this. The price of the stock has increased by 1.72% since.
  • CEO Jean Jacques Bienaime sold 4,000 shares of BMRN stock on 10/31/2012 at the average price of 37.96. Jean Jacques Bienaime owns at least 174,691 shares after this. The price of the stock has increased by 27.61% since.
  • CEO Jean Jacques Bienaime sold 3,000 shares of BMRN stock on 10/22/2012 at the average price of 41.86. Jean Jacques Bienaime owns at least 175,691 shares after this. The price of the stock has increased by 15.72% since.
  • CEO Jean Jacques Bienaime sold 2,000 shares of BMRN stock on 10/19/2012 at the average price of 42.72. Jean Jacques Bienaime owns at least 175,691 shares after this. The price of the stock has increased by 13.39% since.
  • CEO Jean Jacques Bienaime sold 3,000 shares of BMRN stock on 10/12/2012 at the average price of 41.32. Jean Jacques Bienaime owns at least 177,691 shares after this. The price of the stock has increased by 17.23% since.

This is the insider trade history vs. stock price of BMRN. For the complete insider trading history of BMRN, click here.




Directors and Officers Recent Trades:



  • Director Elaine J Heron sold 135,000 shares of BMRN stock on 11/09/2012 at the average price of 46.79. Elaine J Heron owns at least 15,900 shares after this. The price of the stock has increased by 3.53% since.
  • Director Alan Lewis sold 15,000 shares of BMRN stock on 11/07/2012 at the average price of 46.8. Alan Lewis owns at least 15,900 shares after this. The price of the stock has increased by 3.5% since.
  • EVP, Chief Medical Officer Henry J Fuchs sold 10,000 shares of BMRN stock on 11/05/2012 at the average price of 46. Henry J Fuchs owns at least 52,277 shares after this. The price of the stock has increased by 5.3% since.
  • EVP, Technical Operations Robert Baffi sold 60,000 shares of BMRN stock on 11/05/2012 at the average price of 47.33. Robert Baffi owns at least 100,413 shares after this. The price of the stock has increased by 2.35% since.
  • VP, Corporate Controller Brian Mueller sold 8,000 shares of BMRN stock on 11/05/2012 at the average price of 47.03. Brian Mueller owns at least 15,340 shares after this. The price of the stock has increased by 3% since.


For the complete insider trading history of BMRN, click here.

About the author:

insider
GuruFocus - Stock Picks and Market Insight of Gurus

Rating: 0.0/5 (0 votes)

Comments

Please leave your comment:


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Hide